Results 101 to 110 of about 3,137 (197)

Are alternative strategies required to accelerate the global elimination of lymphatic filariasis? Insights from mathematical models [PDF]

, 2018
Background: With the 2020 target year for elimination of lymphatic filariasis (LF) approaching, there is an urgent need to assess how long mass drug administration (MDA) programs with annual ivermectin + albendazole (IA) or diethylcarbamazine ...
Brown, Paul E., de Vlas, Sake J., de Vos, Anneke S., Hollingsworth, T. Déirdre, Irvine, Michael A., Kloek, Marielle, Kontoroupis, Periklis, Michael, E., Prada, Joaquín M., Smith, Morgan E., Stolk, Wilma A., Subramanian, Swaminathan, Touloupou, Panayiota   +12 more
core   +6 more sources

Orbital Loiasis Masquerading as Orbital Cellulitis: A Case Series

Annals of Health Research, 2016
Background: Orbital loiasis is a rare ocular disease which is sparsely reported in the literature. It is caused by the human filarial parasite, Loa loa, which is rarely found in other continents except in Africa and among African immigrants.
Otulana OT, Ajibode HA, Bodunde OT, Onabolu OO   +3 more
doaj  

Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns

Parasites & Vectors, 2018
Background Onchocerciasis and lymphatic filariasis (LF) are major filarial infections targeted for elimination in most endemic sub-Saharan Africa (SSA) countries by 2020/2025.
Jorge Cano, Maria-Gloria Basáñez, Simon J. O’Hanlon, Afework H. Tekle, Samuel Wanji, Honorat G. Zouré, Maria P. Rebollo, Rachel L. Pullan   +7 more
doaj   +1 more source

Clinical manifestations of loiasis in an endemic area in the Congo [PDF]

, 1990
The functional symptomatology of loiasis was studied in 101 Congolese subjects living in a village in a highly endemic area. 27.7 % of them were carriers of #Loa loa$ microfilariae. 5.9 % were infected with #Mansonella perstans$.
Apembet, J.D., Carme, B., Noireau, François, Nzoulani, A.   +3 more
core  

A rare case of loiasis clinically manifested 9 years after the last epidemiological exposure

Microbiologia Medica
A 37-year-old Cameroonian patient, residing in Italy for the past nine years without returning to his home country, showed up at the Emergency Department of Cittadella Hospital with acute hyperemia of the conjunctival tissue, tearing, itching ...
Giorgia Bizzotto, Stefania De Toni, Monica Trambaioli, Paola Cornoldi, Roberto Ghirardo, A. Ruggeri, Gianfranco Biasio, A. Leo   +7 more
semanticscholar   +1 more source

First case of ivermectin-induced severe hepatitis [PDF]

, 2017
Loiasis, caused by the filarial parasite Loa loa, is endemic in West and Central Africa. Ivermectin has been shown to be an effective treatment of loiasis. We report the case of a 20-year-old woman originally from Cameroon who was infected by the L.
Beck, Bernhard, Hatz, Christoph, Steuerwald, Michael, Veit, Olivia   +3 more
core  

Analysing change based on two measures taken under different conditions.

, 2005
Consider an analysis of change using two measurements on each individual taken from two periods of a longitudinal study, where the measurement conditions were different at each study period.
Clarke, Paul S
core   +1 more source

Rapid mapping of schistosomiasis and other neglected tropical diseases in the context of integrated control programmes in Africa [PDF]

, 2017
There is growing interest and commitment to the control of schistosomiasis and other so-called neglected tropical diseases (NTDs). Resources for control are inevitably limited, necessitating assessment methods that can rapidly and accurately identify and
BROOKER, S., GYAPONG, J. O., KABATEREINE, N. B., STOTHARD, J. R., UTZINGER, J.   +4 more
core  

Impact of repeated mass ivermectin administration using a community directed approach on L. loa infection in Chrysops silacea of the rain forest and forest savanna of Cameroon

Parasite Epidemiology and Control
Background: Loiasis is an endemic filarial infection in the rainforest zone of West and Central Africa. Repeated annual community-directed treatment with ivermectin (CDTI) delivered for several years to control onchocerciasis has been shown to reduce the
Glory N. Amambo, Fanny F. Fombad, Patrick W. Chounna Ndongmo, Raphael Awah Abong, Abdel Jelil Njouendou, Amuam Andrew Beng, Theobald Mue Nji, Mathias Eyong Esum, Jerome Fru-Cho, Manuel Ritter, Deribe Kebede, Peter Ivo Enyong, Achim Hoerauf, Benjamin Koudou, Moses Bockarie, Samuel Wanji   +15 more
doaj   +1 more source

Visceral leishmaniasis (kala-azar) outbreak in Somali refugees and Kenyan shepherds, Kenya. [PDF]

, 2001
Boelaert, M, Boussery, G, Ejikon, P, Henckaerts, K, van Peteghem, J   +4 more
core   +2 more sources